Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptorsXiaoliu Zhang, K Sugita, Itaru Kuroda et al.|Leukemia|2012Cited by 17
Specific induction of CD33 expression by E2A–HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factorKoshi Akahane, K Sugita, Takeshi Inukai et al.|Leukemia|2010Cited by 14